Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Breast Neoplasms and SLC29A1[original query] |
---|
Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy. European journal of cancer (Oxford, England : 1990) 2014 Mar 50 (4): 698-705. Lee Soo-Youn, Im Seock-Ah, Park Yeon Hee, Woo Sook Young, Kim Seonwoo, Choi Moon Ki, Chang Wonjin, Ahn Jin Seok, Im Young-Hyu |
Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11). ESMO open 2021 8 6 (5): 100236. Cho E H, Kim J-Y, Im S-A, Jung K H, Sohn J, Lee K S, Chae Y S, Lee K H, Kim J H, Jang J-H, Ahn J H, Park M S, Lee S-Y, Park Y |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: